ES535711A0 - Procedimiento para preparar una composicion para el tratamiento topico de acne - Google Patents

Procedimiento para preparar una composicion para el tratamiento topico de acne

Info

Publication number
ES535711A0
ES535711A0 ES535711A ES535711A ES535711A0 ES 535711 A0 ES535711 A0 ES 535711A0 ES 535711 A ES535711 A ES 535711A ES 535711 A ES535711 A ES 535711A ES 535711 A0 ES535711 A0 ES 535711A0
Authority
ES
Spain
Prior art keywords
acne
prepare
procedure
composition
topical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535711A
Other languages
English (en)
Other versions
ES8608535A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16435683A external-priority patent/JPS6056921A/ja
Priority claimed from JP15700984A external-priority patent/JPS6136219A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8608535A1 publication Critical patent/ES8608535A1/es
Publication of ES535711A0 publication Critical patent/ES535711A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ES535711A 1983-09-07 1984-09-06 Procedimiento para preparar una composicion para el tratamiento topico de acne Expired ES8608535A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16435683A JPS6056921A (ja) 1983-09-07 1983-09-07 皮膚外用剤
JP15700984A JPS6136219A (ja) 1984-07-27 1984-07-27 皮膚外用剤

Publications (2)

Publication Number Publication Date
ES8608535A1 ES8608535A1 (es) 1986-06-16
ES535711A0 true ES535711A0 (es) 1986-06-16

Family

ID=26484601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535711A Expired ES8608535A1 (es) 1983-09-07 1984-09-06 Procedimiento para preparar una composicion para el tratamiento topico de acne

Country Status (6)

Country Link
US (1) US4657901A (es)
EP (1) EP0138029B1 (es)
AU (1) AU570998B2 (es)
DE (1) DE3485408D1 (es)
ES (1) ES8608535A1 (es)
GR (1) GR80293B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
SE462139B (sv) 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
JP2937667B2 (ja) * 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5529987A (en) * 1993-08-04 1996-06-25 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
EP0714308A4 (en) * 1993-08-26 1998-07-29 Univ California METHOD, COMPOSITIONS AND DEVICES FOR THE DELIVERY OF NAKED POLYNUCLEOTIDES THAT ENCODE BIOLOGICALLY ACTIVE PEPTIDES
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US6969529B2 (en) * 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US7459283B2 (en) 2002-02-04 2008-12-02 Elan Pharma International Limited Nanoparticulate compositions having lysozyme as a surface stabilizer
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7998507B2 (en) * 2000-09-21 2011-08-16 Elan Pharma International Ltd. Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US20030064084A1 (en) * 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
JP4776229B2 (ja) * 2002-07-16 2011-09-21 エラン ファーマ インターナショナル，リミティド 安定なナノ粒子活性物質の液体投与組成物
US20050272819A1 (en) * 2003-07-31 2005-12-08 Arye Rubinstein Use of alkylureas for treating acne
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2900575B1 (fr) * 2006-05-05 2008-10-17 Anteis Sa Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US10548862B2 (en) * 2017-12-29 2020-02-04 Lester J. Wu Topical formulation and method for preventing or treating acne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions

Also Published As

Publication number Publication date
ES8608535A1 (es) 1986-06-16
EP0138029A3 (en) 1988-06-29
AU570998B2 (en) 1988-03-31
GR80293B (en) 1985-01-08
EP0138029B1 (en) 1992-01-02
AU3243484A (en) 1985-03-14
DE3485408D1 (de) 1992-02-13
EP0138029A2 (en) 1985-04-24
US4657901A (en) 1987-04-14

Similar Documents

Publication Publication Date Title
ES535711A0 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
ES529965A0 (es) Una composicion para rociar
AR230186A1 (es) Metodo para el tratamiento de una composicion que incluye el factor viii
ES529594A0 (es) Procedimiento para preparar nuevos acidos 3-amino-1-benzazepin-2-ona-1-alcanoicos
BR8405797A (pt) Composto,composicao,processo para controlar vegetacao indesejada e processo para a preparacao do composto
GB2088717B (en) A composition for the topical treatment of acne
IT8147606A0 (it) Composizione per il trattamento topico dell'acne
ES539883A0 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pi- rrolidinonas
ES532789A0 (es) Procedimiento para el tratamiento de napas no-tejidas
ES549151A0 (es) Perfeccionamientos en una maquina para el tratamiento de unamateria en banda
ES506108A0 (es) Procedimiento para preparar una composicion insecticida si- nergistica
ES530461A0 (es) Procedimiento para preparar nuevos azoles
BR8401886A (pt) Composicao curavel;processo para formar um fluoroelastomero
BR8404011A (pt) Composto,composicao herbicida,processo herbicida,e processos para produzir o dito composto
MX158289A (es) Composicion para acondicionar el cabello
ES550241A0 (es) Procedimiento para preparar nuevos derivados imidazo
MX160317A (es) Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa
ES555559A0 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES550240A0 (es) Procedimiento para preparar nuevos derivados imidazo
IT1194185B (it) Composizione per il trattamento dell'acne
ES544117A0 (es) Procedimiento para preparar nuevos bencimidazoles
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
ES549804A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES2016229A4 (es) Proceso para producir n-fosfonometilglicina
GB2163051A (en) Medicinal composition for the treatment or prevention of acne by topical application